Industries > Pharma > Global Ophthalmic Drugs Market Forecast 2017-2027

Global Ophthalmic Drugs Market Forecast 2017-2027

Dry Eye, Glaucoma Drugs, Retinal Disorders Drugs and Allergic, Inflammatory & Infective Drugs

PUBLISHED: 14 June 2017
PAGES: 306
PRODUCT CODE: PHA0202
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0202 Categories: , Tag:

The global ophthalmic drugs market is expected to grow at a CAGR of 4.0% in the first half of the forecast period. The market is expected to grow at a CAGR of 5.6% from 2017-2027. The market is estimated at $23bn in 2016 and $28.1bn in 2021. In 2016, the retinal disorder drugs submarket held 40% of the share in this market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 306-page report you will receive 125 tables and 113 figures – all unavailable elsewhere.

The 306-page report provides clear detailed insight into the global ophthalmic drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Global Ophthalmic Drugs market forecasts from 2017-2027

• This report also breaks down the revenue forecasts to 2027 for the global ophthalmic drugs market by the leading submarkets:
– Retinal Disorder Drugs
– Allergic, Inflammatory & Infective Drugs
– Glaucoma Drugs
– Dry Eye Drugs
– Other Ophthalmic Drugs

Global Ophthalmic Drugs Market Forecast 2017-2027

• This report includes revenue forecasts to 2027 for the following ophthalmic drugs:
– Eylea
– Lucentis
– Avastin
– Visudyne
– Jetrea
– Pataday
– Vigamox
– Patanol
– TobraDex
– Cravit
– AzaSite
– Acular
– Lumigan and Ganfort
– Xalatan/Xalacom
– Travatan/Travatan Z and DuoTrav
– Alphagan/Alphagan P and Combigan
– Azopt
– Trusopt
– Zioptan
– Cosopt
– Tapros/Taflotan
– Restasis
– Refresh
– Hyalein
– Diquas

• This report provides individual revenue forecasts to 2027 for these national markets:
– The US
– Japan
– EU5: Germany, France, the UK, Spain, Italy
– Russia
– China
– India
– Brazil
– Rest of the World

• Our study provides a SWOT analysis and discusses Porter’s Five Forces analysis that influence the global ophthalmic drugs market

• Our report provides discussion on the ophthalmic drugs that are currently in the development pipeline

• Our study discusses the selected leading companies that are the major players in the ophthalmic drugs industry:
– Novartis
– Regeneron
– Allergan
– Roche
– Valeant
– Santen
– Bayer
– Pfizer
– Senju

Visiongain’s study is intended for anyone requiring commercial analyses for the global ophthalmic drugs market. You find data, trends and predictions.

Buy our report today Global Ophthalmic Drugs Market Forecast 2017-2027: Dry Eye, Glaucoma Drugs, Retinal Disorders Drugs and Allergic, Inflammatory & Infective Drugs.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Ophthalmic Drugs Market Forecast 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Ophthalmic Drugs Market Forecast 2017-2027


Latest Pharma news

Visiongain Publishes Biopharmaceuticals Contract Manufacturing Market Report 2022-2032

Ageing population will be more susceptible to such diseases and is one of the key factors driving the growth of the global biological drugs market. In most of the developed world, the share of elderly population is almost touching a quarter of the population.

26 January 2022

READ

Visiongain Publishes Topical Drug Delivery Market Report 2022-2032

Some of the factors driving the market growth are the increasing prevalence of skin and eye diseases, high incidences of burn incidences and the growing prevalence of diabetes.

26 January 2022

READ

Visiongain Publishes Decentralized Clinical Trials Market Report 2022-2032

The growing adoption advanced e-clinical solutions, rising focus on clinical research, increasing investment in R&D, and adoption of decentralized clinical trials by biopharmaceutical companies are some of the major factors that drive the growth of the global decentralized clinical trials market.

24 January 2022

READ

Visiongain Publishes Nasal Drug Delivery Technology Market Report 2022-2032

The nasal drug delivery market will expand rapidly due to rising patient preference for nasal medication delivery due to ease of administration and efficacy, increased self-administration practises, and increased demand for home healthcare equipment.

18 January 2022

READ

Categories